Finance

Beta
Lists
301331:SHE
Enwei Pharmaceutical Co Ltd
CN¥22.75
+3.88%
(+0.85) 1D
Jun 12, 3:04:58 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301331...
Open
CN¥21.90
High
CN¥22.99
Low
CN¥21.63
Mkt. cap
2.34B
Avg. vol.
1.98M
Volume
1.96M
Dividend
4.53%
Quarterly dividend
CN¥0.26
Ex-dividend date
May 28, 2026
P/E ratio
48.56
52-wk high
CN¥39.66
52-wk low
CN¥21.52
EPS
CN¥0.47
Shares outstanding
102.89M
No. of employees
2K
Open
CN¥21.90
High
CN¥22.99
Low
CN¥21.63
Mkt. cap
2.34B
Avg. vol.
1.98M
Volume
1.96M
Dividend
4.53%
Quarterly dividend
CN¥0.26
Ex-dividend date
May 28, 2026
P/E ratio
48.56
52-wk high
CN¥39.66
52-wk low
CN¥21.52
EPS
CN¥0.47
Shares outstanding
102.89M
No. of employees
2K
News stories
From sources across the web
About Enwei Pharmaceutical Co Ltd
CEO-
Employees1.5K
FoundedMay 19, 2005
Headquarters-
SectorPharmaceutical industry
Websiteenwei.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
252.72M
187.63M
263.92M
175.33M
Cost of goods sold
125.17M
102.65M
123.62M
77.69M
Cost of revenue
125.17M
102.65M
123.62M
77.69M
Research and development expenses
1.45M
1.76M
1.22M
1.11M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
92.45M
91.00M
108.50M
82.73M
Operating expense
98.69M
93.18M
115.42M
85.17M
Total operating expenses
223.86M
195.83M
239.04M
162.86M
Operating income
28.86M
-8.20M
24.87M
12.47M
Other non operating income
-431.18K
341.20K
-843.50K
-62.65K
EBT including unusual items
27.74M
-2.54M
20.98M
13.88M
EBT excluding unusual items
29.96M
-6.27M
25.60M
13.52M
Income tax expense
5.70M
-782.36K
5.62M
1.38M
Effective tax rate
20.56%
30.78%
26.77%
9.93%
Other operating expenses
3.29M
2.36M
3.57M
1.89M
Net income
22.04M
-1.76M
15.36M
12.50M
Net profit margin
8.72%
-0.94%
5.82%
7.13%
Earnings per share
-
-
-
-
Interest and investment income
2.34M
2.19M
1.88M
1.69M
Interest expense
-816.54K
-606.94K
-308.97K
-578.12K
Net interest expenses
1.53M
1.59M
1.57M
1.11M
Depreciation and amortization charges
-
-
-
-
EBITDA
40.12M
3.02M
36.41M
24.01M
Gain or loss from assets sale
263.27K
-263.27K
138.01K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer